Literature DB >> 3300287

Plasma exchange in patients with rapidly progressive idiopathic IgA nephropathy: a report of two cases and review of literature.

K N Lai, F M Lai, A C Leung, C P Ho, J Vallance-Owen.   

Abstract

Primary IgA nephropathy is generally considered an indolent disease, but progression to chronic renal failure is not uncommon, and a rapidly progressive course is observed in some cases, especially when extensive fibrocellular crescents are present. The therapeutic benefit of immunosuppression and plasma exchange remains controversial. We described two patients with primary IgA nephropathy and rapidly progressive renal failure. Both patients showed extensive glomerulosclerosis and crescent formation in their renal biopsies. Corticosteroid and immunosuppressive therapy failed to control the progression of the disease, and plasma exchanges were performed. In both cases, the serum creatinine and creatinine clearance initially improved with plasma exchange and the rapid progression of renal failure was apparently halted. In one patient, the serum creatinine rose when treatment was discontinued and fell again when plasma exchange was recommenced. Nevertheless, the long-term benefit of plasma exchange in crescentic IgA nephropathy was unsatisfactory as the renal function continued to deteriorate in the following 12 months despite an initial stabilization.

Entities:  

Mesh:

Year:  1987        PMID: 3300287     DOI: 10.1016/s0272-6386(87)80014-8

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  4 in total

Review 1.  Treatment of IgA nephropathy.

Authors:  C Y Lin
Journal:  Springer Semin Immunopathol       Date:  1994

2.  Plasma exchange combined with immunosuppressive treatment in a child with rapidly progressive IgA nephropathy.

Authors:  Shuichiro Fujinaga; Yoshiyuki Ohtomo; Daisuke Umino; Hiroshi Mochizuki; Hitohiko Murakami; Toshiaki Shimizu; Yuichiro Yamashiro; Kazunari Kaneko
Journal:  Pediatr Nephrol       Date:  2007-02-07       Impact factor: 3.714

Review 3.  The treatment of glomerulonephritis in children.

Authors:  G B Haycock
Journal:  Pediatr Nephrol       Date:  1988-04       Impact factor: 3.714

4.  Role of therapeutic apheresis in the treatment of pediatric kidney diseases.

Authors:  Shweta Shah; Catherine Joseph; Poyyapakkam Srivaths
Journal:  Pediatr Nephrol       Date:  2021-05-15       Impact factor: 3.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.